Manufacturing vaccines during covid-19 cmos/cdmos to the rescue (Record no. 16918)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220627143112.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220627b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 16834 |
| Author | Bhalgat, Mahesh |
| 245 ## - TITLE STATEMENT | |
| Title | Manufacturing vaccines during covid-19 cmos/cdmos to the rescue |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.53(11), Nov |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mumbai |
| Name of publisher, distributor, etc. | Indian Journal of Pharmaceutical Science |
| Year | 2021 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 6-9p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The Healthcare sector was never in greater focus than in 2020. With the pandemic continuing unabated, the world looked to Science and the scientific community for deliverance. And Science did not disappoint. In less than a year of the pandemic, thanks to concerted global efforts, more than 150 vaccine candidates became available as a possible cure for COVID-19. While 2020 was all about discovering a vaccine, 2021 is going to be about how to take the vaccines to market in the shortest possible time. With more than 2.6 million deaths worldwide (figures as on 9 March, 2021) and counting, the need for speed cannot underscored. However, to decipher the manufacturing challenge, one needs to understand what goes behind producing a vaccine — raw materials, technology and a complex manufacturing process. And finally, how and why Contract Manufacturing Organizations (CMOs)/ Contract Development and Manufacturing Organizations (CDMOs) are better positioned to bridge the gap between vaccine demand and supply, safely and at speed. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4639 |
| Topical term or geographic name entry element | PHARMACEUTICS |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 16835 |
| Co-Author | Manjunatha, Satish Kumar |
| 773 0# - HOST ITEM ENTRY | |
| Place, publisher, and date of publication | New Delhi Indian Pharmaceutical Association |
| International Standard Serial Number | 0031-6849 |
| Title | Pharma times |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://ipapharma.org/wp-content/uploads/2021/12/Pharma-Times-November-2021-Low-Resolution.pdf |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| School of Pharmacy | School of Pharmacy | Archieval Section | 2022-06-27 | 2022-0904 | 2022-06-27 | 2022-06-27 | Articles Abstract Database |